RETN and cryohydrocytosis: Paired t-test comparisons between pre- and post-therapy variants in the CHC patients who completed anti-HCV therapy showed that at 24-weeks post-therapy, the levels of ALT (99.0 + /−90.5 vs. 21.0 + /−14.6 U/L, p < 0.001), APRI (1.42 + /−1.60 vs. 0.48 + /−0.39, p < 0.001) and resistin (13.24 + /−17.18 vs. 8.19 + /−4.96 ng/ml, p < 0.001) decreased but that of TC (170.7 + /−31.9 vs.186.0 + /−35.7 mg/dL, p < 0.001) and TG (98.3 + /−43.2 vs. 115.9 + /−65.9 mg/dL, p < 0.001) levels increased in patients with SVR.